痛风与非痛风人群的果糖吸收不良:病例对照研究
该病例对照研究将100例痛风患者与年龄性别匹配的无痛风对照比较,用35g果糖负荷的氢甲烷呼气试验测吸收不良率,并在35对亚组中测240分钟血尿酸反应。两组果糖吸收不良率无显著差异(48% vs 52%,p=0.67);痛风患者果糖负荷后血尿酸累积增量显著低于对照,且95%患者服用别嘌醇,提示别嘌醇可能抑制果糖诱导的血尿酸升高。
要点
- 痛风与非痛风人群果糖吸收不良率相似,无显著差异。
- 痛风患者果糖负荷后血尿酸累积增量显著低于对照。
- 别嘌醇可能抑制果糖负荷诱导的血尿酸升高。
核心结论
- 痛风与非痛风人群的果糖吸收不良率相似(48% vs 52%,p=0.67)。
- 接受别嘌醇治疗的痛风患者果糖负荷后血尿酸升高幅度显著低于对照,提示可能无需限制膳食果糖。
研究设计与样本
- 病例对照研究,100例痛风患者与年龄性别匹配的无痛风对照各100例。
- 低果糖饮食后行35g果糖负荷的氢甲烷呼气试验测吸收不良。
- 亚组35对病例对照测果糖负荷后240分钟血尿酸反应。
主要发现
- 果糖吸收不良率病例与对照无显著差异(48% vs 52%,p=0.67)。
- 病例血尿酸累积增量iAUC0-240显著低于对照[0.97 (0.56) vs 4.78 (0.55),p<0.001]。
- 病例Cmax显著低于对照[0.38 (0.003) vs 0.40 (0.003),p<0.001]。
- 95%的病例正在接受别嘌醇治疗。
- 吸收不良者与正常吸收者间iAUC0-240或Cmax无显著差异,与病例对照状态无关。
临床怎么用
- 接受别嘌醇治疗的痛风患者可能无需限制膳食果糖摄入。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Higher fructose intake has been associated with hyperuricaemia and gout. Some individuals malabsorb fructose in the small intestine. The aims of this study were to determine the rate of fructose malabsorption and the effects of gout and fructose malabsorption on serum urate in people with and without gout. METHODS: A total of 100 people with gout (cases) were age and gender matched with one control without gout. After a low fructose diet, fructose malabsorption was measured using a hydrogen and methane breath test with a 35g fructose load. In a subgroup of 35 cases and 35 controls, serum urate response to the fructose load over 240 minutes was measured. RESULTS: There was no significant difference in the rate of fructose malabsorption between cases and controls (48% vs. 52%; p = 0.67). Cases had a significantly lower mean (SEM) serum urate cumulative incremental concentration from baseline-240 minutes (iAUC0-240) compared to controls 0.97 (0.56) vs. 4.78 (0.55); p < 0.001. Cmax was significantly lower in cases compared to controls [0.38 (0.003) vs. 0.40 (0.003); p < 0.001]. 95% of cases were receiving allopurinol. There was no significant difference between iAUC0-240 or Cmax for malabsorbers compared to normal absorbers irrespective of case-control status. The mean (SEM) increase in serum urate between baseline and 30 minutes was 0.04 (0.004)mmol/l in the controls compared to 0.009 (0.002) in the cases (p < 0.001). CONCLUSION: The rates of fructose malabsorption are similar in people with and without gout. Allopurinol inhibits the increase in serum urate induced by a fructose load suggesting that people with gout receiving allopurinol may not need to restrict dietary intake of fructose.
引用
- Batt C, Fanning N, Drake J, et al. Fructose malabsorption in people with and without gout: A case-control study. Semin Arthritis Rheum. 2017. PMID: 28457529. doi:10.1016/j.semarthrit.2017.03.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。